The Future of Chronic Graft-Versus-Host Disease: Introduction to the 2020 National Institutes of Health Consensus Development Project Reports-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Future of Chronic Graft-Versus-Host Disease: Introduction to the 2020 National Institutes of Health Consensus Development Project Reports

Published:2021-06 Issue:6 Volume:27 Page:448-451
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Pavletic Steven Z.,Martin Paul J.,Schultz Kirk R.,Lee Stephanie J.

Funder

Amgen

AstraZeneca

National Institutes of Health

National Cancer Institute

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference14 articles.

1. Epidemiology and treatment of chronic graft-versus-host disease post-allogeneic hematopoietic cell transplantation (HCT): a US claims analysis;Bachier;Transplant Cell Ther,2021

2. Risk factors for graft-versus-host disease in haploidentical hematopoietic cell transplantation using post-transplant cyclophosphamide;Im;Biol Blood Marrow Transplant,2020

3. Prospective, randomized, double-blind, phase III clinical trial of anti-T-lymphocyte globulin to assess impact on chronic graft-versus-host disease-free survival in patients undergoing HLA-matched unrelated myeloablative hematopoietic cell transplantation;Soiffer;J Clin Oncol,2017

4. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and staging working group report;Filipovich;Biol Blood Marrow Transplant,2005

5. 2014 National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: preface to the series;Pavletic;Biol Blood Marrow Transplant,2015

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease prevention;Blood Advances;2024-08-15

2. Ocular graft host disease after allogeneic stem cell transplant: unique risk factors and outcomes;Delta Journal of Ophthalmology;2024-04

3. Oral manifestations of systemic disorders – part 2;Den norske tannlegeforenings Tidende;2024-02-15

4. Novel therapies for graft versus host disease with a focus on cell therapies;Frontiers in Immunology;2023-10-05

5. Perspectives on oral chronic graft-versus-host disease from immunobiology to morbid diagnoses;Frontiers in Immunology;2023-06-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3